









Markets
/
Stocks
/
nasdaq-opch
/

Option Care Health Inc

OPCH

26.205USD

-2.465-8.60%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

4.25BMarket Cap

20.13P/E TTM



Option Care Health Inc

26.205

-2.465-8.60%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Option Care Health Inc

Currency: USD Updated: 2025-10-29

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Option Care Health Inc's Score

Industry at a Glance

Industry Ranking

9 / 78

Overall Ranking

66 / 4623

Industry

Healthcare Providers & Services

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 11 analysts

Buy

Current Rating

37.667

Target Price

+33.57%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Option Care Health Inc Highlights

StrengthsRisks

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 93 full-service pharmacies and 84 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, heart failure, chronic inflammatory disorders, immunoglobulin infusion, bleeding disorders infusion, nutrition support infusion, neurological disorders, and others. The Company’s home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 26.71% year-on-year.

High Profit Growth

The company's net income leads the industry, with the latest annual income totaling USD 5.00B.

Fairly Valued

The company’s latest PE is 22.70, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 164.70M shares, decreasing 16.41% quarter-over-quarter.

Held by Stanley Druckenmiller

Star Investor Stanley Druckenmiller holds 636.85K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-29

The company's current financial score is 7.53, which is higher than the Healthcare Providers & Services industry's average of 7.24. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.42B, representing a year-over-year increase of 15.39%, while its net profit experienced a year-over-year increase of 4.75%.

Score

Industry at a Glance

Previous score

7.53

Change



Financials

6.01

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

8.30

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.57

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

8.42

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.35

Key Metrics

Free cash flow

No Data

Option Care Health Inc's Company Valuation

Currency: USD Updated: 2025-10-29

The company’s current valuation score is 6.65, which is lower than the Healthcare Providers & Services industry's average of 7.09. Its current P/E ratio is 22.70, which is 75.76% below the recent high of 39.90 and 20.55% above the recent low of 18.04.

Score

Industry at a Glance

Previous score

6.65

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 9/78

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-29

The company’s current earnings forecast score is 8.36, which is higher than the Healthcare Providers & Services industry's average of 7.60. The average price target for Option Care Health Inc is 39.00, with a high of 40.00 and a low of 30.00.

Score

Industry at a Glance

Previous score

8.36

Change

Support & Resistance

No Data

Analyst Rating

Based on 11 analysts

Buy

Current Rating

37.667

Target Price

+31.38%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

Total

Median

Average

Company name

Ratings

Analysts

Option Care Health Inc

OPCH

CVS Health Corp

CVS

HCA Healthcare Inc

HCA

Teladoc Health Inc

TDOC

Tenet Healthcare Corp

THC

Universal Health Services Inc

UHS

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-29

The company’s current price momentum score is 8.85, which is higher than the Healthcare Providers & Services industry's average of 7.13. Sideways: Currently, the stock price is trading between the resistance level at 29.50 and the support level at 27.05, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.71

Change

0.14

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(5)

Neutral(2)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

0.010

Neutral

RSI(14)

37.131

Neutral

STOCH(KDJ)(9,3,3)

64.145

Sell

ATR(14)

0.899

High Vlolatility

CCI(14)

-166.689

Sell

Williams %R

55.978

Sell

TRIX(12,20)

0.040

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(6)

Neutral(0)

Buy(0)

Indicators

Value

Direction

MA5

27.765

Sell

MA10

27.952

Sell

MA20

27.508

Sell

MA50

27.959

Sell

MA100

29.043

Sell

MA200

30.733

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-29

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Providers & Services industry's average of 6.96. The latest institutional shareholding proportion is 101.48%, representing a quarter-over-quarter decrease of 5.23%. The largest institutional shareholder is The Vanguard, holding a total of 17.98M shares, representing 11.08% of shares outstanding, with 2.20% decrease in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

BlackRock Institutional Trust Company, N.A.

18.17M

-5.35%

The Vanguard Group, Inc.

Star Investors

17.98M

-1.55%

Wellington Management Company, LLP

13.33M

-18.65%

Durable Capital Partners LP

8.24M

+134.25%

State Street Investment Management (US)

6.18M

-4.50%

Fuller & Thaler Asset Management Inc.

4.60M

+9.43%

Geode Capital Management, L.L.C.

4.11M

-4.46%

Fidelity Management & Research Company LLC

4.04M

+3.45%

Dimensional Fund Advisors, L.P.

3.56M

+0.64%

Arrowstreet Capital, Limited Partnership

3.41M

+108.96%

Risk Assessment

Currency: USD Updated: 2025-10-29

The company’s current risk assessment score is 7.95, which is higher than the Healthcare Providers & Services industry's average of 5.45. The company's beta value is 0.89. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.